RecruitingPHASE1, PHASE2NCT06408337

Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate.

Studying Cleft palate

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Elisa María Cubiles Montero de Espinosa
Intervention
implantation with an autologous human palatal mucosa substitute made of nanostructured fibrin-agarose generated by tissue engineering (BIOCLEFT).(procedure)
Enrollment
15 enrolled
Eligibility
All sexes
Timeline
2024 – 2028

Study locations (1)

Collaborators

Andalusian Network for Design and Translation of Advanced Therapies

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06408337 on ClinicalTrials.gov

Other trials for Cleft palate

Additional recruiting or active studies for the same condition.

See all trials for Cleft palate →

← Back to all trials